Literature DB >> 27750040

TNFa knockdown in the retina promotes cone survival in a mouse model of autosomal dominant retinitis pigmentosa.

Tapasi Rana1, Pravallika Kotla1, Roderick Fullard1, Marina Gorbatyuk2.   

Abstract

Expression of T17M rhodopsin (T17M) in rods activates the Unfolded Protein Response (UPR) and leads to the development of autosomal dominant retinitis pigmentosa (adRP). The rod death occurs in adRP retinas prior to cone photoreceptor death, so the mechanism by which cone photoreceptors die remains unclear. Therefore, the goal of the study was to verify whether UPR in rods induces TNFa-mediated signaling to the cones and to determine whether the TNFa deficit could prevent adRP cone cell death. Primary rod photoreceptors and cone-derived 661W cells transfected with siRNA against TNFa were treated with tunicamycin to mimic activation of UPR in T17M retinas expressing normal and reduced TNFa levels. The 661W cells were then exposed to recombinant TNFa to evaluate cell viability. In vivo, the role of TNFa was assessed in T17M TNFa+/- mice by electroretinography, optical coherence tomography, histology, immunohistochemistry, and a cytokine enzyme-linked immunosorbent assay. Rods overexpressed and secreted TNFa in response to UPR activation. The recombinant TNFa treatment lowered the number of viable cones, inducing cell death through elevation of pro-inflammatory cytokines and caspase-3/7 activity. The TNFa deficiency significantly protected adRP retinas. The photopic ERG amplitudes and the number of surviving cones dramatically increased in T17M TNFa+/- mice. This neuroprotection was associated with a reduced level of pro-inflammatory cytokines. Our results indicate that rod photoreceptors, following UPR activation during adRP progression, secrete TNFa and signal a self-destructive program to the cones, resulting in their cell death. TNFa therefore holds promise as a therapeutic target for treatment of adRP.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cone survival; Retinal degeneration; T17M rhodopsin; Transgenic mice; Tumor necrosis factor; Unfolded protein response

Mesh:

Substances:

Year:  2016        PMID: 27750040      PMCID: PMC6056179          DOI: 10.1016/j.bbadis.2016.10.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  52 in total

1.  IRE1 signaling affects cell fate during the unfolded protein response.

Authors:  Jonathan H Lin; Han Li; Douglas Yasumura; Hannah R Cohen; Chao Zhang; Barbara Panning; Kevan M Shokat; Matthew M Lavail; Peter Walter
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

2.  Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo.

Authors:  Pascale Kropf; José M Fuentes; Eva Fähnrich; Luis Arpa; Shanthi Herath; Verena Weber; Germán Soler; Antonio Celada; Manuel Modolell; Ingrid Müller
Journal:  FASEB J       Date:  2005-04-05       Impact factor: 5.191

3.  Correspondence to: Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.

Authors:  Miguel A Zapata; Joel Suárez; Teresa Minoves; Dulce Moncho; Anna Farriols; José Garcia-Arumi
Journal:  Retina       Date:  2013-06       Impact factor: 4.256

4.  CCL3 production by microglial cells modulates disease severity in murine models of retinal degeneration.

Authors:  Hideo Kohno; Tadao Maeda; Lindsay Perusek; Eric Pearlman; Akiko Maeda
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

Review 5.  TNF-alpha signaling in glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

6.  Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa.

Authors:  Noriko Yoshida; Yasuhiro Ikeda; Shoji Notomi; Keijiro Ishikawa; Yusuke Murakami; Toshio Hisatomi; Hiroshi Enaida; Tatsuro Ishibashi
Journal:  Ophthalmology       Date:  2012-09-15       Impact factor: 12.079

7.  Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa.

Authors:  Claudio Punzo; Karl Kornacker; Constance L Cepko
Journal:  Nat Neurosci       Date:  2008-12-07       Impact factor: 24.884

8.  Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid.

Authors:  Chang Luo; Mei Chen; Heping Xu
Journal:  Mol Vis       Date:  2011-06-14       Impact factor: 2.367

9.  Microglia-derived TNFα induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma.

Authors:  J Guadagno; X Xu; M Karajgikar; A Brown; S P Cregan
Journal:  Cell Death Dis       Date:  2013-03-14       Impact factor: 8.469

10.  Modulation of cellular signaling pathways in P23H rhodopsin photoreceptors.

Authors:  Olga S Sizova; Vishal M Shinde; Austin R Lenox; Marina S Gorbatyuk
Journal:  Cell Signal       Date:  2013-12-27       Impact factor: 4.315

View more
  4 in total

Review 1.  Endoplasmic reticulum stress: New insights into the pathogenesis and treatment of retinal degenerative diseases.

Authors:  Marina S Gorbatyuk; Christopher R Starr; Oleg S Gorbatyuk
Journal:  Prog Retin Eye Res       Date:  2020-04-06       Impact factor: 21.198

Review 2.  Neurodegeneration: Keeping ATF4 on a Tight Leash.

Authors:  Priyamvada M Pitale; Oleg Gorbatyuk; Marina Gorbatyuk
Journal:  Front Cell Neurosci       Date:  2017-12-15       Impact factor: 5.505

Review 3.  Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies.

Authors:  Lorena Olivares-González; Sheyla Velasco; Isabel Campillo; Regina Rodrigo
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

4.  Gypenosides Alleviate Cone Cell Death in a Zebrafish Model of Retinitis Pigmentosa.

Authors:  Xing Li; Reem Hasaballah Alhasani; Yanqun Cao; Xinzhi Zhou; Zhiming He; Zhihong Zeng; Niall Strang; Xinhua Shu
Journal:  Antioxidants (Basel)       Date:  2021-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.